Dutch pharma trade group the Association of Innovative Medicines (VIG) has made a statement reaffirming its commitment to ...
Major regulators advanced cutting-edge therapies, sharpened safety oversight, and streamlined policies this week. In Europe, ...
US pharma major Eli Lilly (NYSE: LLY) has struck a new strategic collaboration with China’s Innovent Biologics (HKEX: 1801) ...
Swiss pharma giant Roche has announced new late-breaking data from the Phase III FENtrepid study showing the investigational ...
Chinese biotech Bio-Thera Solutions (SHE: 688177) has signed commercialization and license agreements with Saudi drugmaker ...
European industry group the European Federation of Industries and Associations (EFPIA) is pressing EU leaders meeting in ...
Canada based clinical-stage pharma company NervGen Pharma today announced its board of directors has unanimously appointed Dr ...
Hungary’s largest drugmaker Gedeon Richter and Japan’s Fuji Pharma are significantly strengthening their strategic alliance.
The US Department of Health and Human Services has agreed to abandon a proposed rebate-based pilot for the 340B drug pricing ...
US pharma major Eli Lilly today announced entry into a definitive agreement to acquire Orna Therapeutics, marking its second ...
A late-stage specialty pharmaceutical company focused on nicotine dependence, with a single lead asset, cytisinicline, being ...
US dermatologics specialist Verrica Pharmaceuticals) today announced the launch of Ycanth in Japan by its partner, Torii Pharmaceutical, a wholly-owned subsidiary of Japan’s Shionogi, for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results